Overview of the Scientific Agenda
The IMPSN Florence 2026 scientific program presents a comprehensive exploration of cutting-edge advances in mucopolysaccharidoses (MPS) and related lysosomal storage disorders. Over three intensive days, the symposium will showcase the latest breakthroughs in artificial intelligence-driven diagnostics, next-generation newborn screening technologies, and revolutionary therapeutic approaches including gene therapy, CRISPR editing, and novel CNS delivery systems. Distinguished keynote speakers, interactive panel discussions, and poster presentations will highlight late-breaking research while fostering collaboration between families, clinicians, researchers, and industry partners. Designed for researchers, healthcare professionals, patient advocates, and industry leaders, the scientific program emphasizes practical applications alongside rigorous research, ensuring that breakthrough discoveries translate into meaningful improvements in patient outcomes and quality of life.